<DOC>
	<DOCNO>NCT02256722</DOCNO>
	<brief_summary>Study compare metabolic electrolyte effect single oral dose 320 mg ritobegron administer alone pre- comedication bisoprolol , propranolol acipimox . In addition , compare metabolic electrolyte effect single dose 320 mg ritobegron single inhalatory dose 100 Î¼g salmeterol</brief_summary>
	<brief_title>In Vivo Specificity KUC 7483 CL Co-administered With Bisoprolol , Propranolol , Acipimox Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>p-Hydroxyamphetamine</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<mesh_term>Bisoprolol</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Acipimox</mesh_term>
	<criteria>Healthy male Age &gt; = 30 &lt; = 60 year Body Mass Index ( BMI ) &gt; = 18.5 &lt; = 29.9 kg/m2 Signed date write informed consent accordance Good Clinical Practice local legislation Any finding medical examination ( include blood pressure , pulse rate ECG ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder , clinically relevant electrolyte disturbance Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History orthostatic hypotension , faint spell blackouts Chronic clinically relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24:00 hour ) within least one month less ten halflives respective drug enrolment study study Use drug might influence result trial 7 day prior enrolment study study Participation another trial investigational drug ( within two month prior administration trial ) Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke trial day Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation ( &gt; 100 mL within four week prior administration trial ) Any laboratory value outside reference range indicative underlying disease poor health Excessive physical activity within last week trial trial Hypersensitivity treatment medication , salmeterol and/or relate drug class Congenital document acquire QT prolongation , previous history symptomatic arrhythmia Systolic BP &lt; 115 mmHg Heart rate rest &gt; 80 bpm &lt; 55 bpm Any screen ECG value outside reference range clinical relevance include , limited PR interval &gt; 220 m , QRS interval &gt; 115 m , QTcB &gt; 420 m , QT ( uncorrected ) &gt; 450 ms History asthma obstructive pulmonary disease . Psoriasis ( medical history relative )</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>